hypaque oral liquid 50gm/120ml
sanofi canada, inc. - diatrizoate sodium - liquid - 50g - diatrizoate sodium 50g - roentgenography
hypaque oral powder 0.9974g/g
sanofi canada, inc. - diatrizoate sodium - powder - 997.4mg - diatrizoate sodium 997.4mg - roentgenography
hypaque sodium liq 50% liquid
sanofi canada, inc. - diatrizoate sodium - liquid - 50% - diatrizoate sodium 50% - roentgenography
hypaque oral liquid - 50g/120ml
nycomed imaging a.s. - diatrizoate sodium - liquid - 50g - diatrizoate sodium 50g - roentgenography
hypaque sodium 50% - liq iv liquid
nycomed imaging a.s. - diatrizoate sodium - liquid - 50% - diatrizoate sodium 50% - roentgenography
ioscan
iotech pty ltd - sodium diatrizoate -
ioscan
regional health ltd - amidotrizoic acid dihydrate 378.65 mg/ml (converted to sodium diatrizoate in situ by sodium hydroxide.); - oral solution - 0.37 g/ml - active: amidotrizoic acid dihydrate 378.65 mg/ml (converted to sodium diatrizoate in situ by sodium hydroxide.) excipient: acesulfame citric acid citrus limon methyl hydroxybenzoate purified water quinoline yellow sodium hydroxide sorbitol - ioscan is a contrast medium for computerised axial tomography examination of the gastrointestinal tract. it should be made up wi th water prior to use, and administered orally. it is indicated primarily for use when barium sulphate is not appropriate.
dbl promethazine hydrochloride
hospira australia pty ltd - promethazine hydrochloride -
dbl™ promethazine hydrochloride
pfizer new zealand limited - promethazine hydrochloride 25 mg/ml - solution for injection - 50 mg/2ml - active: promethazine hydrochloride 25 mg/ml excipient: glacial acetic acid sodium acetate trihydrate sodium edetate sodium metabisulfite water for injection - dbl™ promethazine hydrochloride injection bp is indicated for the following conditions: treatment of allergic reactions such as: uncomplicated allergic conditions of the immediate type, eg. pruritus, urticaria and angioedema, when oraltherapy is impossible or contraindicated treatment and prevention of vomiting including: motion sickness; drug induced nausea; prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery, such as procedures with a high incidence of postoperative vomiting (eg. gynaecological surgery, strabismus or middle ear surgery, and electroconvulsive therapy); in patients with a past history of motion sickness or post operative vomiting; and in patients in whom avoidance of vomiting is crucial (eg. neurosurgery and eye surgery); promethazine has sedative effects and it is also used in: preoperative, postoperative and obstetric (during labour) sedation.
dbl promethazine hydrochloride 50mg/2ml injection
pfizer australia pty ltd - promethazine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; sodium metabisulfite; glacial acetic acid; sodium acetate; water for injections - indication as 8 january 2004: promethazine hydrochloride injection bp is indicated for the following conditions: treatment of allergic reactions such as: uncomplicated allergic conditions of the immediate type, e.g. pruritus, urticaria and angioedema, when oral therapy is impossible or contraindicated. treatment and prevention of vomiting including: motion sickness; drug induced nausea; prevention and control of nausea and vomiting associated with certain types of anaesthesia and surgery, such as procedures with a high incidence of post-operative vomiting (e.g. gynaecological surgery, strabismus or middle ear surgery, and electroconvulsive therapy); in patients with a past history of motion sickness or post-operative vomiting; and in patients in whom avoidance of vomiting is crucial (e.g. neurosurgery and eye surgery). promethazine has sedative effects and it is also used in: pre-operative, post-operative and obstetric (during labour) sedation.